Benitec Biopharma Inc.
BNTC
$14.10
$0.322.32%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 92.16% | 632.40% | 284.23% | 162.30% | 1,953.53% |
Total Receivables | -85.59% | -94.34% | -96.23% | -92.45% | 316.36% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 21.71% | 129.94% | 3.10% | -11.62% | -56.42% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 79.37% | 384.62% | 342.86% | 392.31% | 384.62% |
Total Current Assets | 90.65% | 624.00% | 278.50% | 158.73% | 1,285.73% |
|
|||||
Total Current Assets | 90.65% | 624.00% | 278.50% | 158.73% | 1,285.73% |
Net Property, Plant & Equipment | 120.71% | 105.75% | -36.14% | -32.58% | -26.75% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -4.60% | -4.26% | -36.79% | -26.36% | -28.69% |
Total Assets | 90.75% | 601.44% | 270.29% | 154.22% | 1,069.58% |
|
|||||
Total Accounts Payable | -85.12% | -46.87% | -77.36% | -40.90% | 18.51% |
Total Accrued Expenses | -19.01% | 28.53% | 12.58% | 28.32% | -13.04% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 24.65% | 18.49% | -52.10% | -24.64% | 3.27% |
Total Finance Division Other Current Liabilities | -72.63% | 223.98% | -24.81% | 25.58% | 45.24% |
Total Other Current Liabilities | -72.63% | 223.98% | -24.81% | 25.58% | 45.24% |
Total Current Liabilities | -63.40% | 104.42% | -46.24% | 0.42% | 23.78% |
|
|||||
Total Current Liabilities | -63.40% | 104.42% | -46.24% | 0.42% | 23.78% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | 888.71% | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -53.71% | 118.32% | -46.85% | -3.18% | 16.42% |
|
|||||
Common Stock & APIC | 36.88% | 57.32% | 41.73% | 32.28% | 41.13% |
Retained Earnings | -19.93% | -14.66% | -12.20% | -12.35% | -13.32% |
Treasury Stock & Other | 5.94% | 14.25% | 27.73% | -27.31% | -7.47% |
Total Common Equity | 105.92% | 748.43% | 390.89% | 187.70% | 23,290.10% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 105.92% | 748.43% | 390.89% | 187.70% | 23,290.10% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 105.92% | 748.43% | 390.89% | 187.70% | 23,290.10% |
|